Cerus Corp
CERS1.295USD
+0.025+1.97%
交易中 （美東）報價延遲15分鐘
247.49M總市值
虧損本益比TTM
關於 Cerus Corp 公司
Cerus Corporation 是一家生物醫學產品公司。該公司專注於開發和商業化 INTERCEPT 血液系統，以提高血液安全性。INTERCEPT 血液系統基於其控制生物複製的專有技術，旨在減少用於輸血的捐獻血液成分中的血源性病原體。其 INTERCEPT 血液系統旨在與血液成分及其某些衍生物一起使用：血小板、血漿、紅細胞，並生產 INTERCEPT 纖維蛋白原複合物 (IFC) 和病原體減少血漿、冷沉澱減少。INTERCEPT 冷沉澱血液系統使用其血漿系統生產 IFC，用於治療和控制與纖維蛋白原缺乏相關的出血，包括大出血。此外，INTERCEPT 冷沉澱血液系統用於生產病原體減少血漿、冷沉澱減少。
公司簡介
公司代碼CERS
公司名稱Cerus Corp
上市日期Jan 31, 1997
CEOMr. William M. (Obi) Greenman
員工數量281
證券類型Ordinary Share
年結日Jan 31
公司地址1220 Concord Avenue
城市CONCORD
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編94520
電話19252886000
網址https://www.cerus.com/
公司代碼CERS
上市日期Jan 31, 1997
CEOMr. William M. (Obi) Greenman
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
304.17K
+24.57%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
289.70K
-64.05%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
182.05K
+49.16%
Dr. Hua Shan, M.D., Ph.D.
Dr. Hua Shan, M.D., Ph.D.
Independent Director
Independent Director
131.10K
+84.39%
Mr. William M. (Obi) Greenman
Mr. William M. (Obi) Greenman
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Jami K. Nachtsheim ,
Jami K. Nachtsheim ,
Independent Director
Independent Director
--
--
Mr. Dean A. Gregory
Mr. Dean A. Gregory
Director
Director
--
--
Dr. Frank R. Witney, Ph.D.
Dr. Frank R. Witney, Ph.D.
Lead Independent Director
Lead Independent Director
--
--
Dr. Richard J. Benjamin, Ph.D.
Dr. Richard J. Benjamin, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Timothy L. (Tim) Moore
Mr. Timothy L. (Tim) Moore
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
304.17K
+24.57%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
289.70K
-64.05%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
182.05K
+49.16%
Dr. Hua Shan, M.D., Ph.D.
Dr. Hua Shan, M.D., Ph.D.
Independent Director
Independent Director
131.10K
+84.39%
Mr. William M. (Obi) Greenman
Mr. William M. (Obi) Greenman
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Jami K. Nachtsheim ,
Jami K. Nachtsheim ,
Independent Director
Independent Director
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Product
43.24M
0.00%
地區USD
名稱
營收
佔比
North America
30.60M
70.77%
Europe and Middle East and Africa
12.21M
28.24%
Other
427.00K
0.99%
業務
地區
業務USD
名稱
營收
佔比
Product
43.24M
0.00%
股東統計
更新時間: 5月22日 週四
更新時間: 5月22日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Baker Bros. Advisors LP
10.12%
ARK Investment Management LLC
10.05%
BlackRock Institutional Trust Company, N.A.
6.77%
The Vanguard Group, Inc.
5.52%
Wasatch Global Investors Inc
4.35%
Other
63.19%
持股股東
持股股東
佔比
Baker Bros. Advisors LP
10.12%
ARK Investment Management LLC
10.05%
BlackRock Institutional Trust Company, N.A.
6.77%
The Vanguard Group, Inc.
5.52%
Wasatch Global Investors Inc
4.35%
Other
63.19%
股東類型
持股股東
佔比
Investment Advisor
29.51%
Hedge Fund
20.42%
Investment Advisor/Hedge Fund
20.22%
Individual Investor
4.69%
Research Firm
3.80%
Family Office
1.22%
Venture Capital
0.10%
Bank and Trust
0.09%
Pension Fund
0.07%
Other
19.86%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
330
149.69M
78.31%
-11.42M
2025Q1
349
154.49M
80.95%
-4.85M
2024Q4
362
150.65M
81.09%
-18.33M
2024Q3
373
152.20M
82.15%
-11.01M
2024Q2
387
150.50M
81.41%
-12.83M
2024Q1
386
146.19M
80.62%
-12.96M
2023Q4
385
141.79M
78.32%
-24.31M
2023Q3
382
146.35M
81.02%
-13.17M
2023Q2
384
145.73M
80.79%
-19.32M
2023Q1
387
151.80M
85.48%
-8.28M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Baker Bros. Advisors LP
19.35M
10.12%
-126.25K
-0.65%
Mar 31, 2025
ARK Investment Management LLC
20.66M
10.81%
-159.61K
-0.77%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
12.94M
6.77%
+28.20K
+0.22%
Mar 31, 2025
The Vanguard Group, Inc.
10.55M
5.52%
+137.20K
+1.32%
Mar 31, 2025
Wasatch Global Investors Inc
8.32M
4.35%
--
--
Mar 31, 2025
Nikko Asset Management Co., Ltd.
6.19M
3.24%
-270.80K
-4.19%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.54M
2.38%
+87.67K
+1.97%
Mar 31, 2025
Senvest Management, LLC
4.41M
2.3%
-1.99M
-31.10%
Mar 31, 2025
State Street Global Advisors (US)
3.80M
1.99%
-8.14K
-0.21%
Mar 31, 2025
D. E. Shaw & Co., L.P.
3.79M
1.98%
+361.80K
+10.55%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ARK Genomic Revolution ETF
0.94%
Invesco NASDAQ Future Gen 200 ETF
0.5%
ARK Innovation ETF
0.23%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.04%
iShares US Small-Cap Equity Factor ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
ARK Genomic Revolution ETF
佔比0.94%
Invesco NASDAQ Future Gen 200 ETF
佔比0.5%
ARK Innovation ETF
佔比0.23%
iShares Micro-Cap ETF
佔比0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.05%
Fidelity Enhanced Small Cap ETF
佔比0.04%
iShares US Small-Cap Equity Factor ETF
佔比0.04%
iShares Russell 2000 Growth ETF
佔比0.02%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
